Bills · S 641
IN COMMITTEE· 119TH CONGRESS
Senate BillS 641Drug safety, medical device, and laboratory regulationCanada
Safe and Affordable Drugs from Canada Act of 2025
INTRO FEB 19· LAST ACTION FEB 19
READING
4MIN
COSPONSORS
7
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because prescription drug prices in the United States are often significantly higher than in other developed countries, including Canada. Many Americans struggle to afford their necessary medications, leading to difficult choices between healthcare and other essential needs. If this bill becomes law, it could provide a pathway for individuals to save money on their prescriptions, potentially making life-saving or quality-of-life-improving drugs more accessible and affordable.
Without this bill, individual importation of prescription drugs from Canada remains generally illegal, and Americans are largely limited to purchasing drugs through the U.S. pharmaceutical supply chain. By changing this, the bill aims to introduce more competition and provide financial relief to consumers, directly addressing a major concern for many voters regarding healthcare costs. It could also put pressure on U.S. drug manufacturers to lower prices if a safe, legal alternative becomes widely available.
KEY PROVISIONS
4AI-extractedPROVISION 01
Allows individuals to import up to a 90-day supply of certain prescription drugs for personal use from U.S. government-approved Canadian pharmacies.
This directly addresses the issue of high prescription drug costs by creating a legal pathway for individuals to access potentially more affordable medications.
PROVISION 02
Requires the U.S. Secretary (who oversees the FDA) to establish rules and certify Canadian pharmacies that meet specific safety and operational standards.
This provision is crucial for ensuring that imported drugs are safe, effective, and purchased from legitimate sources, preventing the flow of counterfeit or substandard medications.
PROVISION 03
Specifies that certain categories of drugs, such as controlled substances, biological products, and those requiring refrigeration, are excluded from personal importation.
These exclusions are important for maintaining control over potentially dangerous substances and drugs that require specialized handling, minimizing safety risks associated with importation.
PROVISION 04
Mandates that the imported drug must have the same active ingredients, dosage, and form as a drug already approved by the U.S. Food and Drug Administration (FDA).
This ensures that individuals are importing medications that are chemically equivalent to those already deemed safe and effective for use in the United States.
SPONSORSHIP
1 + 7
D· Minnesota
YRS IN OFFICE
—
BILLS LED
94
COSPONSOR BREAKDOWNBIPARTISAN · 33%
DEM 5 REP 1 IND 1
ACTION TIMELINE
2 EVENTSFEB 19
Introduced in Senate
FEB 19
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
BILL INFO
TypeSenate Bill
NumberS 641
Congress119th
StatusIn Committee
IntroducedFeb 19, 2025
Last actionFeb 19, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · HEALTH, EDUCATION, LABOR, AND PENSIONS COMMITTEE · INTRODUCED FEB 19, 2025
Senate BillS 641Drug safety, medical device, and laboratory regulationCanada
Safe and Affordable Drugs from Canada Act of 2025
INTRODUCED FEB 19, 2025· LAST ACTION FEB 19, 2025
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
7
COMPLEXITY
Moderate
